Cargando…

A Comprehensive Review of Pegvaliase, an Enzyme Substitution Therapy for the Treatment of Phenylketonuria

OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of a phenylalanine-metabolizing enzyme indicated to reduce blood phenylalanine concentrations, pegvaliase injection. DATA SOURCES: Searches of MEDLINE (1946-September 1, 2018) were conducted using the ter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hydery, Tasmina, Coppenrath, Valerie Azzopardi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589953/ https://www.ncbi.nlm.nih.gov/pubmed/31258325 http://dx.doi.org/10.1177/1177392819857089

Ejemplares similares

Successful desensitization of Pegvaliase (Palynziq®) in a patient with phenylketonuria
por: Patrawala, Meera, et al.
Publicado: (2020)

Case-control study about the acceptance of Pegvaliase in Phenylketonuria
por: Krämer, Johannes
Publicado: (2020)

Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018)

A benefit-risk analysis of pegvaliase for the treatment of phenylketonuria: A study of patients' preferences
por: Sri Bhashyam, Sumitra, et al.
Publicado: (2019)

Nutritional status of adults with phenylketonuria on pegvaliase: A 15-month prospective study
por: Viau, Krista, et al.
Publicado: (2023)

Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria
por: Qi, Yulan, et al.
Publicado: (2021)

Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics()
por: Adams, Darius, et al.
Publicado: (2021)

Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria
por: Zori, Roberto, et al.
Publicado: (2019)

Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase
por: Rocha, Júlio César, et al.
Publicado: (2021)

Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data
por: Lah, Melissa, et al.
Publicado: (2022)

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials
por: Gupta, Soumi, et al.
Publicado: (2018)

Reinstitution of pegvaliase therapy during lactation
por: Rohr, Frances, et al.
Publicado: (2022)

Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study
por: Longo, Nicola, et al.
Publicado: (2018)

Retraction notice to “Case-control study about the acceptance of Pegvaliase in Phenylketonuria” Molecular Genetics and Metabolism Reports 22 (2020) 100557.
por: Krämer, Johannes
Publicado: (2021)

Continuation of pegvaliase treatment during pregnancy: A case report
por: Boyer, Monica, et al.
Publicado: (2021)

Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program
por: Lavitas, Pavel, et al.
Publicado: (2016)

Methodology for conducting a comprehensive product review in managed care
por: Linnerooth, Sara, et al.
Publicado: (2023)

Protein Substitute Requirements of Patients with Phenylketonuria on BH4 Treatment: A Systematic Review and Meta-Analysis
por: Ilgaz, Fatma, et al.
Publicado: (2021)

First 1.5 years of pegvaliase clinic: Experiences and outcomes
por: Sacharow, Stephanie, et al.
Publicado: (2020)

Protein substitutions as new-generation pharmanutrition approach to managing phenylketonuria
por: Keskin, Fatma Nur, et al.
Publicado: (2022)

Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report
por: Rohr, Fran, et al.
Publicado: (2020)

Nutrition management of PKU with pegvaliase therapy: update of the web-based PKU nutrition management guideline recommendations
por: Cunningham, Amy, et al.
Publicado: (2023)

New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
por: Harding, Cary O
Publicado: (2010)

Best practices in designing preapproval information engagements for US health care decision makers
por: Dodda, Sai, et al.
Publicado: (2023)

New Strategies for the Treatment of Phenylketonuria (PKU)
por: Strisciuglio, Pietro, et al.
Publicado: (2014)

Transitioning of protein substitutes in patients with phenylketonuria: evaluation of current practice
por: Yilmaz, Ozlem, et al.
Publicado: (2022)

Payer perceptions and use of value assessment tools in the United States
por: Westrich, Kimberly, et al.
Publicado: (2023)

The complete European guidelines on phenylketonuria: diagnosis and treatment
por: van Wegberg, A. M. J., et al.
Publicado: (2017)

Bone Status in Patients with Phenylketonuria: A Systematic Review
por: de Castro, María José, et al.
Publicado: (2020)

Phenylketonuria
por: Hudson, Frederick
Publicado: (1969)

Phenylketonuria: nutritional advances and challenges
por: Giovannini, Marcello, et al.
Publicado: (2012)

Mutational landscape of phenylketonuria in Iran
por: Ajami, Naser, et al.
Publicado: (2023)

Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population
por: Kouris, George, et al.
Publicado: (2018)

Bone health in phenylketonuria: a systematic review and meta-analysis
por: Demirdas, Serwet, et al.
Publicado: (2015)

Recent Advances in Phenylketonuria: A Review
por: Zuñiga Vinueza, Andrea M
Publicado: (2023)

Genetic etiology and clinical challenges of phenylketonuria
por: Elhawary, Nasser A., et al.
Publicado: (2022)

Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Ilgaz, Fatma, et al.
Publicado: (2019)

A systematic review of cognitive functioning in early treated adults with phenylketonuria
por: Hofman, Denise Leonne, et al.
Publicado: (2018)

The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018)

Development of an mRNA replacement therapy for phenylketonuria
por: Perez-Garcia, Carlos G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2otkso2a9oli0k52d4fk0jtd2q